Inventor · disambiguated record
Mark R. Bray
Also filed as: BRAY MARK R · BRAY MARK ROBERT
11 granted patents·8 pending applications·42 citations·filing 1998–2023
85Inventor score
Top patents by PatentIndex Score
19 records- 0184US8114870B2Method of treating disease states using substituted pyrazole compoundsXIAO XIAO-YI·Filed 2009·Granted Feb 14, 2012·10 cites·4 claims
- 0280US7563787B2Substituted pyrazole compoundsMIIKANA THERAPEUTICS INC·Filed 2006·Granted Jul 21, 2009·6 cites·6 claims
- 0375US9642856B2Treatment for pancreatic cancerUNIV HEALTH NETWORK·Filed 2014·Granted May 9, 2017·5 cites·15 claims
- 0470US2023390294A1Combination therapies for inhibition of ttk protein kinaseUNIV HEALTH NETWORK·Filed 2023·Application pending·0 cites
- 0568US10875863B2RIPK2 inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2019·Granted Dec 29, 2020·0 cites·15 claims
- 0668US7713915B1Cytotoxic heteromeric protein combinatorial librariesMOLECULAR TEMPLATES INC·Filed 1998·Granted May 11, 2010·21 cites·28 claims
- 0764US11766437B2Combination therapies for inhibition of TTK protein kinaseUNIV HEALTH NETWORK·Filed 2018·Granted Sep 26, 2023·0 cites·13 claims
- 0864US2021261554A1Ripk2 inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2020·Application pending·0 cites
- 0959US2025049787A1Treatment for acute myeloid leukemia or lymphomaUNIV HEALTH NETWORK·Filed 2022·Application pending·0 cites
- 1058US12109215B2Combination therapies for inhibition of polo-like kinase 4UNIV HEALTH NETWORK·Filed 2018·Granted Oct 8, 2024·0 cites·8 claims
- 1156US10239881B2RIPK2 inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2015·Granted Mar 26, 2019·0 cites·16 claims
- 1253US12325700B2Crystal form S4 of the PLK4 inhibitor (1R,2S)-(e)-2-(3-(4-((cis-2,6-dimethylmorpholino)methyl)styryl)-1 h-imidazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one fumarateUNIV HEALTH NETWORK·Filed 2020·Granted Jun 10, 2025·0 cites·25 claims
- 1353US2023174549A1Salt and crystal forms of 4-amino-5-(6-(4-methylpiperazin-1-yl)-1h-benzo[d]imidazol-2-yl)thieno[2,3-b]pyridin-6(7h)-oneUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 1452US2024150462A1Lilrb1 and lilrb2-binding molecules and uses thereforUNIV HEALTH NETWORK·Filed 2022·Application pending·0 cites
- 1551US2023165871A1Combination therapies for inhibition of polo-like kinase 4UNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 1649US12286476B2FCMR-binding molecules and uses thereofUNIV HEALTH NETWORK·Filed 2020·Granted Apr 29, 2025·0 cites·33 claims
- 1748US2023144869A1Methods for treating cytokine release syndromeUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 1846US12404327B2LILRB3-binding molecules and uses thereforUNIV HEALTH NETWORK·Filed 2020·Granted Sep 2, 2025·0 cites·20 claims
- 1944US2022153834A1Tsg-6 antibodies and uses thereforUNIV HEALTH NETWORK·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark R. Bray files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →